World Health Organization (W.H.O.) Director-General Tedros Adhanom Ghebreyesus announced on Wednesday that trials for two potential therapeutics to fight the Ebola Bundibugyo virus would begin next week.
Ebola Bundibugyo is the strain of the virus currently fueling an ongoing outbreak in the Democratic Republic of the Congo (DRC) and Uganda, found to have infected over a thousand people since May and most recently identified in a returning health worker in France. Bundibugyo is a less common strain than those that fueled previous outbreaks in the DRC and Guinea, such as the Zaire and Sudan strains of the virus. Currently, no approved vaccine…
Read the full article at BREITBART.COM
